Publications by authors named "Betty K Hamilton"

55Publications

Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation Recipients.

Biol Blood Marrow Transplant 2020 Aug 19;26(8):1505-1510. Epub 2020 May 19.

Department of Pediatric Hematology Oncology and Bone Marrow Transplant, Cleveland Clinic Foundation, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.03.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371542PMC
August 2020

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

Biol Blood Marrow Transplant 2020 Aug 17;26(8):1459-1468. Epub 2020 May 17.

Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391266PMC
August 2020

To D or not to D: vitamin D in hematopoietic cell transplantation.

Bone Marrow Transplant 2020 Apr 25. Epub 2020 Apr 25.

Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0904-7DOI Listing
April 2020

Patient-reported outcomes in acute graft-versus-host disease: optimizing patient care and clinical trial endpoints.

Bone Marrow Transplant 2020 Aug 10;55(8):1533-1539. Epub 2020 Mar 10.

Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0850-4DOI Listing
August 2020

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.

Front Immunol 2020 12;11:181. Epub 2020 Feb 12.

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2020.00181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028690PMC
February 2020

Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantation.

Br J Haematol 2020 Apr 20;189(2):318-322. Epub 2020 Jan 20.

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16336DOI Listing
April 2020

Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation.

Hematol Oncol Stem Cell Ther 2020 Mar 24;13(1):32-39. Epub 2019 Dec 24.

Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hemonc.2019.10.001DOI Listing
March 2020

Disability Related to Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2020 Apr 24;26(4):772-777. Epub 2019 Oct 24.

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.10.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180104PMC
April 2020

Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.

Hematol Oncol Stem Cell Ther 2020 Sep 11;13(3):160-165. Epub 2019 Oct 11.

Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hemonc.2019.09.002DOI Listing
September 2020

The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.

Biol Blood Marrow Transplant 2019 12 5;25(12):2468-2473. Epub 2019 Aug 5.

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.07.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900444PMC
December 2019

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2019 09 11;25(9):1869-1874. Epub 2019 May 11.

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755054PMC
September 2019

Patient-Reported Outcomes with Chimeric Antigen Receptor T Cell Therapy: Challenges and Opportunities.

Biol Blood Marrow Transplant 2019 05 28;25(5):e155-e162. Epub 2018 Nov 28.

Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511294PMC
May 2019

Health-Related Quality of Life after Autologous Stem Cell Transplantation for Multiple Myeloma.

Biol Blood Marrow Transplant 2018 08 4;24(8):1546-1553. Epub 2018 Apr 4.

Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183016
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.03.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108907PMC
August 2018

Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2018 05 31;24(5):1029-1034. Epub 2018 Jan 31.

Blood and Marrow Transplantation Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.01.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953837PMC
May 2018

Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.

Biol Blood Marrow Transplant 2018 02 12;24(2):393-399. Epub 2017 Oct 12.

Division of Hematology/Oncology, Vanderbilt University, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767523PMC
February 2018

Biomarker Panel for Chronic Graft-Versus-Host Disease.

J Clin Oncol 2016 08 23;34(22):2583-90. Epub 2016 May 23.

Jeffrey Yu, Kushi Kushekhar, Mohammad Abu Zaid, and Sophie Paczesny, Indiana University School of Medicine, Indianapolis, IN; Barry E. Storer, Paul J. Martin, Mary E. Flowers, John A. Hansen, Stephanie J. Lee, Qing Zhang, Philip R. Gafken, and Yuko Ogata, Fred Hutchinson Cancer Research Center; Barry E. Storer, University of Washington School of Medicine, Seattle, WA; Mukta Arora, University of Minnesota, Minneapolis, MN; Corey Cutler, Dana-Farber Cancer Institute, Boston, MA; Madan Jagasia, Vanderbilt University, Nashville, TN; Joseph Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; Betty K. Hamilton, Cleveland Clinic Foundation, Cleveland, OH; George L. Chen, Roswell Park Cancer Institute, Buffalo, NY; and Iskra Pusic, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.9615DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012688PMC
August 2016

Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.

Biol Blood Marrow Transplant 2016 06 16;22(6):1141-1144. Epub 2016 Mar 16.

Blood and Marrow Transplantation Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.011DOI Listing
June 2016

Phase I/II Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers.

Oncologist 2015 Aug 17;20(8):952-9. Epub 2015 Jun 17.

Developmental Therapeutics Program, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Cancer Therapeutics Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524755PMC
August 2015

Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic Syndromes.

Clin Lymphoma Myeloma Leuk 2015 Aug 2;15(8):489-95. Epub 2015 Apr 2.

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.03.017DOI Listing
August 2015

Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.

Am J Hematol 2015 Feb 19;90(2):144-8. Epub 2014 Nov 19.

Blood & Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23882DOI Listing
February 2015

Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report.

J Med Case Rep 2013 Jan 14;7:18. Epub 2013 Jan 14.

Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1752-1947-7-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562165PMC
January 2013

Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia.

Stem Cells 2012 Aug;30(8):1581-6

Department of Hematologic Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.1140DOI Listing
August 2012